129 related articles for article (PubMed ID: 15152615)
1. [Early treatment of a Bence-Jones-kappa-light-chain-paraproteinemia].
Bethge WA; Einsele H
Internist (Berl); 2004 Apr; 45(4):466-7. PubMed ID: 15152615
[No Abstract] [Full Text] [Related]
2. Immunochemical Diagnosis of Multiple Myeloma.
Lyubimova NV; Timofeev YS; Abaev VM; Votyakova OM; Kushlinskii NE
Bull Exp Biol Med; 2018 May; 165(1):84-87. PubMed ID: 29797132
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
[TBL] [Abstract][Full Text] [Related]
4. The development of cast nephropathy in multiple myeloma.
Iggo N; Winearls CG; Davies DR
QJM; 1997 Nov; 90(11):653-6. PubMed ID: 9474345
[No Abstract] [Full Text] [Related]
5. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma.
Uchida S; Matsuda O; Yokota T; Takemura T; Ando R; Kanemitsu H; Hamaguchi H; Miyake S; Marumo F
Nephron; 1990; 55(3):332-5. PubMed ID: 2115147
[TBL] [Abstract][Full Text] [Related]
6. Bence-Jones myeloma with pleural effusion: response to alpha-interferon and combined chemotherapy.
Makino S; Yamahara S; Nagake Y; Kamura J
Intern Med; 1992 May; 31(5):617-21. PubMed ID: 1504423
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolar lavage].
Burkhardt O; Dickgreber NJ; Bühling F; Waldburg N; Merker HJ; Welte T
Dtsch Med Wochenschr; 2003 Sep; 128(38):1951-4. PubMed ID: 14502447
[TBL] [Abstract][Full Text] [Related]
8. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
[No Abstract] [Full Text] [Related]
9. Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains.
Mead GP; Carr-Smith HD; Drayson MT; Bradwell AR
Clin Lab; 2003; 49(1-2):25-7. PubMed ID: 12593472
[No Abstract] [Full Text] [Related]
10. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
Solomon A; McLaughlin CL; Capra JD
J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxic potential of Bence Jones proteins.
Solomon A; Weiss DT; Kattine AA
N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
[TBL] [Abstract][Full Text] [Related]
12. Necrobiotic xanthogranuloma with lambda paraproteinemia: case report of successful treatment with melphalan and prednisone.
Criado PR; Vasconcellos C; Pegas JR; Lopes LF; Ramos CF; Tebcherani AJ; Valente NY
J Dermatolog Treat; 2002 Jun; 13(2):87-9. PubMed ID: 12060508
[TBL] [Abstract][Full Text] [Related]
13. V-domain deposition of lambda Bence Jones protein in the renal tubular epithelial cells in a patient with the adult Fanconi syndrome with myeloma.
Isobe T; Kametani F; Shinoda T
Amyloid; 1998 Jun; 5(2):117-20. PubMed ID: 9686306
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidosis associated with multiple myeloma].
Hirota K; Furusawa S
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):480-3. PubMed ID: 9851195
[No Abstract] [Full Text] [Related]
15. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein.
Solomon A
J Clin Invest; 1978 Jan; 61(1):97-108. PubMed ID: 618916
[TBL] [Abstract][Full Text] [Related]
16. Serum test for assessment of patients with Bence Jones myeloma.
Bradwell AR; Carr-Smith HD; Mead GP; Harvey TC; Drayson MT
Lancet; 2003 Feb; 361(9356):489-91. PubMed ID: 12583950
[TBL] [Abstract][Full Text] [Related]
17. Relapsing Henoch-Schönlein syndrome with renal involvement in a patient with an IgA monoclonal gammopathy. A study of the results of immunosuppressant and cytotoxic therapy.
Dosa S; Cairns SA; Mallick NP; Lawler W; Williams G
Nephron; 1980; 26(3):145-8. PubMed ID: 6774272
[No Abstract] [Full Text] [Related]
18. Multiple myeloma. II. The value of melphalan.
Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
[No Abstract] [Full Text] [Related]
19. [Tetrameric Bence Jones protein--case report and review of the literature].
Inoue N; Togawa A; Yawata Y
Nihon Ketsueki Gakkai Zasshi; 1984 Nov; 47(7):1456-9. PubMed ID: 6442513
[No Abstract] [Full Text] [Related]
20. Synthesis and metabolism of Bence Jones protein and calculation of tumour burden in patients with Bence Jones myeloma.
Durie BG; Cole PW; Chen HS; Himmelstein KJ; Salmon SE
Br J Haematol; 1981 Jan; 47(1):7-19. PubMed ID: 7437347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
